Overview
What is Hemophilia Services Consortium Inc?
The Hemophilia Services Consortium Inc, located in New York City, is a nonprofit organization dedicated to enhancing accessible and affordable care for individuals with hemophilia and other bleeding disorders in the New York metropolitan area. They ensure a reliable supply of blood-clotting concentrates and other essential medications by purchasing and dispensing these treatments cooperatively and on a centralized basis to their patron hospitals. Besides, they offer additional services permitted for tax-exempt corporations under sections 501(e) and 501(c)(3) of the Code.
What are the reviews and ratings of this charity?
Charity Navigator rating: 74%, Two-Star out of Four Star rating.
Hemophilia Services Consortium Inc has received a Two-Star rating from Charity Navigator, indicating a moderate level of accountability and financial health. The organization excels in having a fully independent board and demonstrating strong oversight in auditing practices. They maintain rigorous policies for conflict of interest and document retention, ensuring transparency in their operations.
However, there are notable areas of concern that contribute to the overall rating. The organization is missing a whistleblower policy, which is essential for protecting employees and stakeholders. Additionally, the absence of publicly posted financial statements on their website and a high liabilities-to-assets ratio raise questions about financial stability and accessibility of information.
Despite these challenges, Hemophilia Services Consortium Inc maintains a solid program expense ratio, indicating that most of its funds are directed toward its mission. Continued improvements in transparency and addressing the financial liabilities could enhance their standing and overall effectiveness in serving the hemophilia community.
This AI summary has been generated from information found on Charity Navigator.
Is Hemophilia Services Consortium Inc legitimate?
Hemophilia Services Consortium Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Hemophilia Services Consortium Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
What is the mission statement of Hemophilia Services Consortium Inc?
The Hemophilia Services Consortium Inc is dedicated to enhancing affordable care for individuals with bleeding disorders in the New York metropolitan area. They do this by ensuring a consistent supply of blood-clotting concentrates and other medications for the treatment of hemophilia and other blood clotting disorders. The consortium purchases and dispenses these essential medicines cooperatively and centrally among its patron hospitals. In addition, they provide other services permitted for tax-exempt corporations under sections 501(e) and 501(c)(3) of the tax code. The primary goal is to make essential treatments accessible and affordable for individuals dealing with these conditions.
Who is the CEO of Hemophilia Services Consortium Inc?
Unavailable
What is the revenue of Hemophilia Services Consortium Inc?
Hemophilia Services Consortium Inc's revenue in 2022 was $20,563,934.
Who are the executives of Hemophilia Services Consortium Inc and what are their salaries?
Here are 17 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Where can I find the form 990 for Hemophilia Services Consortium Inc?
Hemophilia Services Consortium Inc's most recent form 990 was submitted in 2022 and can be accessed here.
Mission Statement of Hemophilia Services Consortium Inc
The Hemophilia Services Consortium Inc is a non-profit organization dedicated to enhancing affordable care for individuals with bleeding disorders in the New York metropolitan area. Through its mission, the consortium aims to ensure an available supply of blood-clotting concentrates and other medications for the treatment of hemophilia and other blood-clotting disorders.
In practice, Hemophilia Services Consortium Inc functions by purchasing and dispensing these essential medications to its patron hospitals on a cooperative, centralized basis. By doing so, the consortium helps to make these life-saving treatments more accessible and affordable for those who need them. In addition to its medication distribution services, the organization provides other permissible services for corporations exempt from taxation under sections 501(e) and 501(c)(3) of the tax code.
The Hemophilia Services Consortium Inc plays a vital role in the healthcare community by addressing the unique needs of individuals with bleeding disorders. By centralizing the purchasing and distribution of necessary medications, the consortium enables hospitals to focus on providing high-quality care to their patients. Furthermore, the organization's mission aligns with the broader goal of improving the overall health and well-being of the community by ensuring that essential treatments are readily available to those who need them.
In summary, the Hemophilia Services Consortium Inc is a compassionate and essential organization that enhances affordable care for individuals with bleeding disorders in the New York metropolitan area. Through its mission to supply blood-clotting concentrates and other medications for the treatment of hemophilia and other blood-clotting disorders, the consortium helps to ensure that these vital treatments are accessible to those who need them most.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
Hemophilia Services Consortium Inc significantly enhances the quality of care for individuals with bleeding disorders in the New York metropolitan area. By ensuring a reliable supply of blood-clotting concentrates and other vital medications, the consortium addresses a critical need for effective treatment in this community.
The organization's cooperative model allows for centralized purchasing and dispensing of essential medications, making it easier for hospitals to provide necessary therapies to their patients. This approach not only improves accessibility but also promotes affordability, making it possible for more people affected by hemophilia and related disorders to receive the care they need.
Furthermore, the consortium plays a vital role in fostering a healthcare environment where individuals with these conditions can manage their health more effectively. By filling the gaps in treatment availability and supporting healthcare providers, the Hemophilia Services Consortium Inc empowers individuals and families affected by bleeding disorders, ultimately leading to better health outcomes and enhanced quality of life.
This information is meant to be a general summary of Hemophilia Services Consortium Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $2,908
- Program Service Revenue: $20,390,179
- Gross Receipts: $20,563,934
Assets and Liabilities:
- Total Assets: $5,868,302
- Total Liabilities: $5,743,891
- Net Assets: $124,411
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
BLOOD FACTOR - HSC
Revenue
$12,594,696
BLOOD FACTOR - AGENT
Revenue
$7,795,483
Organization Details
Founding Year
1997
Phone
(212) 585-6489Main Address
525 EAST 68TH STREET BOX 156, NEW YORK, NY, 10065
NTEE Category
Code: E21Z - Health
If you are a representative of Hemophilia Services Consortium Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.